During hypoxia, EVs derived from cancer cells are enriched in angiogenic factors, such as VEGF and Hypoxia-inducible factor 1-alpha having metastatic potential; this suggests that tumor cells can adjust to a hypoxic microenvironment by secreting EVs to promote angiogenesis or metastasis [82]. Here, VEGFA is linked to cancer.